87 related articles for article (PubMed ID: 33995277)
1. Urine steroid metabolomics as a diagnostic tool in primary aldosteronism.
Prete A; Lang K; Pavlov D; Rhayem Y; Sitch AJ; Franke AS; Gilligan LC; Shackleton CHL; Hahner S; Quinkler M; Dekkers T; Deinum J; Reincke M; Beuschlein F; Biehl M; Arlt W
J Steroid Biochem Mol Biol; 2024 Mar; 237():106445. PubMed ID: 38104729
[TBL] [Abstract][Full Text] [Related]
2. KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma.
Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Mizobuchi A; Harada T; Yamaji T; Hashimoto Y; Yoshimura K; Nakano Y; Goto C; Yusoff FM; Nakashima A; Higashi Y
Hypertens Res; 2023 Sep; 46(9):2213-2227. PubMed ID: 37463983
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of Primary Aldosteronism After Surgery in Aldosterone-producing Adenoma With
Aiga K; Kometani M; Aono D; Yoneda T
JCEM Case Rep; 2023 Jan; 1(1):luac032. PubMed ID: 37908261
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Outcomes of KCNJ5 Mutated Aldosterone-Producing Adenoma: A Systematic Review.
Kato H; Kitamoto T; Kimura S; Sunouchi T; Hoshino Y; Hidaka N; Tsurutani Y; Ito N; Makita N; Nishikawa T; Nangaku M; Inoue K
Endocr Pract; 2024 Apr; ():. PubMed ID: 38657793
[TBL] [Abstract][Full Text] [Related]
5. The predictors of long-term outcomes after targeted therapy for primary Aldosteronism.
Chen YY; Huang SC; Pan CT; Peng KY; Lin LY; Chan CK; Shun CT
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S135-S140. PubMed ID: 38097431
[TBL] [Abstract][Full Text] [Related]
6. KCNJ5 mutations in familial and non-familial primary aldosteronism.
Al-Salameh A
Eur J Endocrinol; 2024 Jun; 190(6):L9-L10. PubMed ID: 38781451
[No Abstract] [Full Text] [Related]
7. Cardiovascular and metabolic characters of
Chang YY; Lee BC; Chen ZW; Tsai CH; Chang CC; Liao CW; Pan CT; Peng KY; Chou CH; Lu CC; Wu VC; Hung CS; Lin YH;
Front Endocrinol (Lausanne); 2023; 14():1061704. PubMed ID: 36950676
[TBL] [Abstract][Full Text] [Related]
8. Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET.
Brooks AF; Winton WP; Stauff J; Arteaga J; Henderson B; Niedbala J; Scott PJH; Viglianti BL
J Nucl Med; 2022 Dec; 63(12):1949-1955. PubMed ID: 35483964
[TBL] [Abstract][Full Text] [Related]
9. [Primary aldosteronism: new insights into familial forms].
van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
[TBL] [Abstract][Full Text] [Related]
10. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
Scholl UI; Lifton RP
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
[TBL] [Abstract][Full Text] [Related]
11. NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict
Lu CC; Yen RF; Peng KY; Huang JY; Wu KD; Chueh JS; Lin WY
Front Endocrinol (Lausanne); 2021; 12():644927. PubMed ID: 33995277
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.
Lu CC; Wu VC; Wu KD; Liu KL; Lin WC; Cheng MF; Tzen KY; Yen RF;
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1375-84. PubMed ID: 24525587
[TBL] [Abstract][Full Text] [Related]
13. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
Oßwald A; Fischer E; Degenhart C; Quinkler M; Bidlingmaier M; Pallauf A; Lang K; Mussack T; Hallfeldt K; Beuschlein F; Reincke M
Eur J Endocrinol; 2013 Nov; 169(5):657-63. PubMed ID: 23946277
[TBL] [Abstract][Full Text] [Related]
14. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
Ip JC; Pang TC; Pon CK; Zhao JT; Sywak MS; Gill AJ; Soon PS; Sidhu SB
ANZ J Surg; 2015 Apr; 85(4):279-83. PubMed ID: 24274318
[TBL] [Abstract][Full Text] [Related]
15. KCNJ5 Somatic Mutation Is a Predictor of Hypertension Remission After Adrenalectomy for Unilateral Primary Aldosteronism.
Vilela LAP; Rassi-Cruz M; Guimaraes AG; Moises CCS; Freitas TC; Alencar NP; Petenuci J; Goldbaum TS; Maciel AAW; Pereira MAA; Silva GV; Pio-Abreu A; Zerbini MCN; Cavalcante ACBS; Carnevale FC; Pilan B; Yamauchi F; Srougi V; Tanno FY; Chambo JL; Latronico AC; Mendonca BB; Fragoso MCBV; Bortolotto LA; Drager LF; Almeida MQ
J Clin Endocrinol Metab; 2019 Oct; 104(10):4695-4702. PubMed ID: 31216002
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
